Advertisement
Perrigo Guides FY24 Well Below Estimates - Update
(RTTNews) - While reporting financial results for the fourth quarter on Tuesday, consumer products company Perrigo Co. plc (PRGO) initiated its adjusted earnings, revenue and organic net sales growth guidance for the full-year 2024.
For fiscal 2024, the company now projects adjusted earnings in a range of $2.50 to $2.65 per share on flat net sales, with organic net sales growth of 1 to 3 percent.
On average, analysts polled by Thomson Reuters expect the company to report earnings of $2.99 per share on revenue growth of 4.7 percent to $4.89 billion for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
Perrigo Recalls Select CVS Health, H-E-B Baby Premium Infant Formula
Perrigo Co. plc is recalling select Premium Infant Formula with Iron Milk-Based Powder sold under CVS Health and H-E-B Baby brands at the retailer and warehouse level citing elevated Vitamin D levels than permitted, according to the U.S. Food and Drug Administration. The recall involves three lots within one batch, or 16,500 cans, of store brand Premium Infant Formula with Iron Milk-Based Powder.
RTTNews
|
hace 375
Perrigo Launches Project Energize To Improve Efficiency, Cut Costs; To Cut 6% Jobs - Update
While reporting financial results for the fourth quarter on Tuesday, consumer products company Perrigo Co. plc (PRGO) said it is launching Project Energize - a global investment and efficiency program to drive the next evolution of capabilities and organizational agility.
RTTNews
|
hace 539
Perrigo Appoints Patrick Lockwood-Taylor As President And CEO
Pharma company Perrigo Company plc (PRGO) announced Thursday the appointment of industry professional Patrick Lockwood-Taylor as its new President, Chief Executive Officer and member of the Board of Directors, effective June 30, 2023.
RTTNews
|
hace 803
Perrigo Says HRA Pharma Submits Application To FDA For OTC Birth Control Pill In The U.S.
Consumer Self-Care Products firm Perrigo Co. plc (PRGO) announced Monday that its company HRA Pharma has submitted its application to the U.S. Food and Drug Administration (FDA) for the first-ever over-the-counter (OTC) birth control pill in the U.S.
RTTNews
|
hace 1135
Canadian Market Modestly Lower In Cautious Trade
After moving modestly higher in early trades, the Canadian market gave up gains as investors digested the nation's inflation data, and closely followed the developments on Russia-Ukraine peace talks front.
RTTNews
|
hace 2h 32min
Swiss Market Ends On Strong Note
After a somewhat subdued start, the Switzerland market gained in strength as the session progressed on Tuesday, to eventually closed on a bright note.
RTTNews
|
hace 3h 12min
European Stocks Close Higher On Russia-Ukraine Peace Deal Hopes
European stocks closed higher on Tuesday as the mood remained positive amid optimism over a potential Russia-Ukraine peace deal, after U.S. President Donald Trump described his meeting with Ukrainian President Volodymyr Zelenskyy and several other European leaders as "very good".
RTTNews
|
hace 3h 36min
U.S. Housing Starts Unexpectedly Surge In July But Building Permits Slump
A report released by the Commerce Department on Tuesday unexpectedly showed a sharp increase by new residential construction in the U.S. in the month of July. The Commerce Department said housing starts shot up by 5.2 percent to an annual rate of 1.428 million in July after spiking by 5.9 percent to an upwardly revised rate of 1.358 million in June.
RTTNews
|
hace 7h 14min
